Lincoln [LINCOLN] vs Windlas Biotech [WINDLAS] Detailed Stock Comparison

Lincoln

NSE
Loading...

Windlas Biotech

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Lincoln wins in 16 metrics, Windlas Biotech wins in 4 metrics, with 0 ties. Lincoln appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricLincolnWindlas BiotechBetter
P/E Ratio (TTM)12.9532.26Lincoln
Price-to-Book Ratio1.674.12Lincoln
Debt-to-Equity Ratio0.006.45Lincoln
PEG Ratio0.771.06Lincoln
EV/EBITDA8.9718.27Lincoln
Profit Margin (TTM)13.71%8.20%Lincoln
Operating Margin (TTM)13.19%9.08%Lincoln
EBITDA Margin (TTM)13.19%9.08%Lincoln
Return on Equity12.26%12.06%Lincoln
Return on Assets (TTM)10.33%8.02%Lincoln
Free Cash Flow (TTM)$737.71M$159.93MLincoln
Dividend Yield0.31%1.23%Windlas Biotech
1-Year Return-26.92%11.76%Windlas Biotech
Price-to-Sales Ratio (TTM)1.782.62Lincoln
Enterprise Value$9.23B$18.75BWindlas Biotech
EV/Revenue Ratio1.472.36Lincoln
Gross Profit Margin (TTM)54.96%38.25%Lincoln
Revenue per Share (TTM)$315$380Windlas Biotech
Earnings per Share (Diluted)$43.13$30.80Lincoln
Beta (Stock Volatility)0.190.28Lincoln
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Lincoln vs Windlas Biotech Stock Performance Analysis

Loading Price Chart...

Lincoln
Windlas Biotech
Lincoln Stock Overview | Windlas Biotech Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lincoln-1.49%3.09%-0.39%-3.20%2.89%-34.64%
Windlas Biotech-0.96%1.00%10.15%9.94%10.55%-3.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lincoln-26.92%92.23%115.24%160.29%160.29%160.29%
Windlas Biotech11.76%336.23%176.17%176.17%176.17%176.17%

News Based Sentiment: Lincoln vs Windlas Biotech

Lincoln

News based Sentiment: MIXED

The month presented a mixed picture for Lincoln Pharmaceuticals, with positive institutional investment countered by declining profitability and a cautious analyst rating. While the dividend and new R&D leadership are positive developments, the overall investment story is currently balanced between potential and risk.

View Lincoln News Sentiment Analysis

Windlas Biotech

News based Sentiment: POSITIVE

Windlas Biotech demonstrated strong revenue growth and received a bullish analyst rating, coupled with proactive investor relations efforts. While institutional holding shifts exist, the overall narrative is positive, suggesting a strengthening investment case.

View Windlas Biotech News Sentiment Analysis

Performance & Financial Health Analysis: Lincoln vs Windlas Biotech

MetricLINCOLNWINDLAS
Market Information
Market Cap i₹11.21B₹20.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i26,42334,079
90 Day Avg. Volume i218,69396,252
Last Close₹551.80₹1,003.00
52 Week Range₹499.00 - ₹979.50₹665.10 - ₹1,198.25
% from 52W High-43.67%-16.29%
All-Time High₹979.50 (Dec 09, 2024)₹1,198.25 (Nov 04, 2024)
% from All-Time High-43.67%-16.29%
Growth Metrics
Quarterly Revenue Growth0.05%0.20%
Quarterly Earnings Growth0.17%0.31%
Financial Health
Profit Margin (TTM) i0.14%0.08%
Operating Margin (TTM) i0.13%0.09%
Return on Equity (TTM) i0.12%0.12%
Debt to Equity (MRQ) i0.006.45
Cash & Liquidity
Book Value per Share (MRQ)₹335.40₹241.38
Cash per Share (MRQ)₹97.95₹114.20
Operating Cash Flow (TTM) i₹967.87M₹396.84M
Levered Free Cash Flow (TTM) i₹823.46M₹609.94M
Dividends
Last 12-Month Dividend Yield i0.31%1.23%
Last 12-Month Dividend i₹1.80₹11.30

Valuation & Enterprise Metrics Analysis: Lincoln vs Windlas Biotech

MetricLINCOLNWINDLAS
Price Ratios
P/E Ratio (TTM) i12.9532.26
Forward P/E iN/AN/A
PEG Ratio i0.771.06
Price to Sales (TTM) i1.782.62
Price to Book (MRQ) i1.674.12
Market Capitalization
Market Capitalization i₹11.21B₹20.84B
Enterprise Value i₹9.23B₹18.75B
Enterprise Value Metrics
Enterprise to Revenue i1.472.36
Enterprise to EBITDA i8.9718.27
Risk & Other Metrics
Beta i0.190.28
Book Value per Share (MRQ) i₹335.40₹241.38

Financial Statements Comparison: Lincoln vs Windlas Biotech

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)LINCOLNWINDLAS
Revenue/Sales i₹1.68B₹2.10B
Cost of Goods Sold i₹801.52M₹1.30B
Gross Profit i₹880.31M₹803.60M
Research & Development iN/AN/A
Operating Income (EBIT) i₹234.93M₹190.76M
EBITDA i₹198.39M₹317.63M
Pre-Tax Income i₹162.47M₹232.57M
Income Tax i₹46.72M₹55.93M
Net Income (Profit) i₹115.75M₹176.64M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)LINCOLNWINDLAS
Cash & Equivalents i₹134.14M₹4.24M
Total Current Assets i₹5.00B₹5.25B
Total Current Liabilities i₹1.06B₹2.49B
Long-Term Debt iN/A₹22.51M
Total Shareholders Equity i₹6.72B₹5.06B
Retained Earnings iN/A₹2.75B
Property, Plant & Equipment i₹1.82B₹2.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)LINCOLNWINDLAS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLINCOLNWINDLAS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i26,42334,079
Average Daily Volume (90 Day) i218,69396,252
Shares Outstanding i20.03M20.96M
Float Shares i8.79M7.57M
% Held by Insiders i0.55%0.64%
% Held by Institutions i0.01%0.10%

Dividend Analysis & Yield Comparison: Lincoln vs Windlas Biotech

MetricLINCOLNWINDLAS
Last 12-Month Dividend i₹1.80₹11.30
Last 12-Month Dividend Yield i0.31%1.23%
3-Year Avg Annual Dividend i₹1.60₹6.27
3-Year Avg Dividend Yield i0.35%0.96%
3-Year Total Dividends i₹4.80₹18.80
Ex-Dividend DateSep 13, 2024Jul 21, 2025